Developer docs
API playgroundTry for free, no card

Search company profiles

STDcheck

Full company profile

uuid000ffo3

Namestring
STDcheck
Legal namestring
FPK Services, LLC
Websiteurl
stdcheck.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

STDcheck.com is a Houston-based direct-to-consumer online STD testing service founded in 2010 by CEO Fiyyaz Pirani, operating as a subsidiary of Analyte Health under the legal entity FPK Services, LLC. The platform enables customers to order FDA-approved and cleared diagnostic tests online or by phone, visit any of 4,500+ CLIA-certified laboratory testing centers nationwide for sample collection, and receive confidential results within 1-2 days via a secure online account. Its catalog spans individual tests priced from $24 (Chlamydia, Gonorrhea, Hepatitis A/B/C, Herpes I & II, HIV antibody, Syphilis, Trichomoniasis, Mycoplasma Genitalium) up to a 10-Test Panel at $349 that includes the only FDA-approved HIV RNA Early Detection Test on the market, plus an extended 13-Test Panel with wellness screenings. The company refuses insurance billing to preserve privacy, supports payment via HSA/FSA and modern wallets, and offers free physician consultation with treatment prescription for positive results.

The business model is primarily transactional one-time test sales to consumers, supplemented by a 40% commission affiliate program through CJ Affiliate by Conversant, a B2B white-label partner program, and nonprofit/educational institute outreach programs that delivered 130,000+ tests in 2021. Customer segments include sexually active adults (primary), minors aged 16-17 served without parental consent, the LGBT community, and college students reached through programs such as the HIV-Positive Scholarship. The company has served over 2 million customers since founding, maintains a 9.8/10 rating across 5,236 reviews, and is BBB accredited, HIPAA-compliant, and FDA/CLIA-aligned, with no external funding rounds disclosed in the available sources.

Short descriptiontext

STDcheck.com is a Houston-based direct-to-consumer online STD testing service that lets customers order FDA-approved tests online, visit 4,500+ CLIA-certified labs nationwide, and receive confidential results in 1-2 days. A subsidiary of Analyte Health, it has served over 2 million customers since 2010.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
online STD testing, sexual health screening, CLIA-certified lab diagnostics, confidential lab testing, direct-to-consumer diagnostics
Industry2 codes
PRIMARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Direct-to-Consumer STD Testing Services
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Direct Test Sales
TypeOne Time License
Description

One-time purchase of individual STD tests or panel packages. Customers pay upfront for testing services rendered at partner laboratory locations. Prices range from $24 for individual tests to $349 for comprehensive 10-Test Panel with HIV RNA Early Detection. Additional revenue from medical consultations for positive results.

stdcheck.com
2Affiliate Program
TypeAffiliate Referral
Description

40% commission on all referred customer purchases through CJ Affiliate by Conversant network. Affiliates receive recurring commissions from customer referrals who purchase within 45-day window.

stdcheck.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Marketing or Sales, Operations, Personnel, Technology or R&D, Others
Pricing details4 tiers
1Individual Tests - Starting at $24
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual STD tests available starting at $24. Tests include Chlamydia, Gonorrhea, Hepatitis A/B/C, Oral Herpes, Genital Herpes, HIV 1 & 2 Antibody (4th Gen), HIV RNA Early Detection, Syphilis, Trichomoniasis, Mycoplasma Genitalium.

stdcheck.com
210-Test Panel - $349 with HIV RNA
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Complete 10-Test Panel screens for chlamydia, gonorrhea, herpes-1 (HSV-1), herpes-2 (HSV-2), HIV Type-1, HIV Type-2, hepatitis A, B and C, and syphilis. Includes HIV RNA Early Detection Test.

stdcheck.com
313-Test Panel - Expanded Coverage
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Comprehensive panel includes everything in the 10-Test Panel plus Trichomoniasis, Mycoplasma Genitalium, and wellness tests for broader coverage.

stdcheck.com
4Affiliate Commission - 40% Revenue Share
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

40% commission on all referred customer purchases. 45-day cookie tracking. Additional bonuses including exclusive $10 discount codes for affiliate audiences.

stdcheck.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

STDcheck sells FDA-approved/cleared STD tests directly to consumers through its website and phone ordering. Customers order tests online, visit one of 4,500+ CLIA-certified testing centers for sample collection, and receive confidential results via a secure online portal within 1-2 days. The offering includes individual tests for specific infections and comprehensive 10-Test and 13-Test Panels, with free physician consultation and treatment prescriptions for positive results.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Results delivered in 1-2 days vs 1-2 weeks at free clinics
+3 more records
Product overview1 text field

STDcheck is an online STD testing platform offering FDA-approved/cleared diagnostic tests through a network of over 4,500 CLIA-certified testing centers nationwide. The core product is the online test ordering and results delivery service, available as comprehensive test panels (10-Test Panel, 13-Test Panel with wellness tests) or individual tests for specific infections including Chlamydia, Gonorrhea, Hepatitis A/B/C, Herpes I & II, HIV (antibody and RNA early detection), Syphilis, Trichomoniasis, and Mycoplasma Genitalium. The platform includes supplementary services such as physician consultation for positive results, an STD Test Recommender tool, and a B2B partner program for white-label services. Results are delivered within 1-2 days via secure online account. The company was founded in 2010 and has served over 2 million customers.

Product and service17 records
110-Test Panel
Categorycore product
Description

Comprehensive 10-disease STD screening panel including HIV-1, HIV-2, gonorrhea, chlamydia, syphilis, herpes 1 & 2, and hepatitis A, B, and C, priced at $349 with HIV RNA Early Detection included. Aimed at sexually active adults seeking a single comprehensive evaluation.

213-Test Panel
Categorycore product
Description

Most comprehensive screening panel covering 10 STDs plus Trichomoniasis, Mycoplasma Genitalium, and wellness tests, designed for broader coverage including HIV 1 & 2 (4th Gen), syphilis, gonorrhea, chlamydia, hepatitis A, B, C, trichomoniasis, mycoplasma genitalium, and herpes 1 & 2.

3Chlamydia & Gonorrhea Panel
Categorycore product
Description

Joint panel test for Chlamydia and Gonorrhea infections using FDA-approved/cleared methodology.

4Herpes I & II Test
Categorycore product
Description

Combined testing for oral herpes (HSV-1) and genital herpes (HSV-2) infections.

5HIV 1 & 2 Antibody (4th Gen) Test
Categorycore product
Description

FDA-cleared 4th generation HIV-1 and HIV-2 antibody test for standard-window HIV screening.

6HIV RNA Early Detection Test
Categorycore product
Description

Only FDA-approved HIV RNA Early Detection Test on the market. Detects HIV genetic material 9-11 days after exposure, earlier than antibody-based tests that require 30+ days.

7Chlamydia Test
Categoryindividual test
Description

Individual FDA-approved/cleared test for Chlamydia infection, available starting at $24.

8Gonorrhea Test
Categoryindividual test
Description

Individual FDA-approved/cleared test for Gonorrhea infection.

9Hepatitis A Test
Categoryindividual test
Description

Individual FDA-approved/cleared test for Hepatitis A infection.

10Hepatitis B Test
Categoryindividual test
Description

Individual FDA-approved/cleared test for Hepatitis B infection.

11Hepatitis C Test
Categoryindividual test
Description

Individual FDA-approved/cleared test for Hepatitis C infection.

12Oral Herpes Test
Categoryindividual test
Description

Individual FDA-approved/cleared test for oral herpes (HSV-1) infection.

13Genital Herpes Test
Categoryindividual test
Description

Individual FDA-approved/cleared test for genital herpes (HSV-2) infection.

14Syphilis Test
Categoryindividual test
Description

Individual FDA-approved/cleared test for Syphilis infection.

15Trichomoniasis Test
Categoryindividual test
Description

Individual FDA-approved/cleared test for Trichomoniasis infection.

16Mycoplasma Genitalium Test
Categoryindividual test
Description

Individual FDA-approved/cleared test for Mycoplasma Genitalium infection.

17Doctor Consultation
Categoryservice
Description

Free physician consultation service for patients who test positive, with licensed doctors reviewing results and able to prescribe treatment for the patient and partner.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Partnerships with various nonprofits and educational institutes for STD testing programs. Testing over 130,000 people for genital herpes in 2021 through these partnerships.

Strategic tierCoreTypeTechnology or Integration
Description

Laboratory testing partner for STD testing services. CLIA-certified lab processing patient samples collected at testing centers.

Strategic tierCoreTypeTechnology or Integration
Description

Laboratory testing partner for STD testing services. CLIA-certified lab processing patient samples collected at testing centers.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Affiliate marketing network managing partner relationships and commission tracking. STDcheck offers 40% commission on referred sales with 45-day cookie tracking through this network.

Strategic tierCoreTypeOthers
Description

Parent company of STDcheck.com. STDcheck is a subsidiary of Analyte Health, which also operates Healthlabs.com, PaternityLabs.com, and UTITreatment.com sister sites.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Ro
TypeBroad incumbent
Description

Direct-to-consumer healthcare company offering telehealth, pharmacy, and at-home lab testing across multiple categories. Comparable patient-facing confidential health platform with significant capital backing, competing for the same DTC health consumer.

TypeDirect peer
Description

Telehealth platform specializing in sexual and reproductive health including STD testing, PrEP, and birth control. Comparable confidential, direct-to-consumer care model for sexual health needs, though with stronger emphasis on telehealth consultations.

TypeDirect peer
Description

Direct-to-consumer at-home diagnostic testing platform offering sexual health tests among many other categories. Competes with STDcheck on confidential testing with home sample collection and telehealth follow-up.

TypeDirect peer
Description

Direct-to-consumer online lab testing service offering confidential STD and other health tests through partner labs. Closely mirrors STDcheck's online ordering, lab center visit, and fast result delivery model.

TypeDirect peer
Description

At-home STD testing company offering FDA-cleared test kits shipped directly to consumers. Most direct competitor to STDcheck specifically focused on sexual health testing, with comparable pricing and confidentiality positioning.

TypeDirect peer
Description

Direct-to-consumer lab testing platform offering at-home test collection kits across multiple categories including sexual health. Closely comparable to STDcheck in offering FDA-cleared tests marketed directly to consumers with online ordering and physician-reviewed results.

TypeBroad incumbent
Description

One of the two largest clinical laboratory companies in the US and an existing STDcheck lab partner. QuestDirect consumer offering directly competes with STDcheck while also powering its backend, creating both partnership and competitive tension.

TypeBroad incumbent
Description

One of the two largest clinical laboratory companies in the US and an existing STDcheck lab partner. Labcorp OnDemand consumer offering competes with STDcheck while also serving as its core processing infrastructure.

TypeDirect peer
Description

Direct-to-consumer STD testing service using partner lab network, closely mirroring STDcheck's model of confidential online ordering with lab center visits for sample collection and fast result delivery.

TypeBroad incumbent
Description

Large direct-to-consumer telehealth platform offering sexual health, hair loss, skincare, and primary care services. Comparable direct-to-consumer confidential care model for sensitive health categories, with significantly broader scope and brand recognition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

STDcheck

Direct-to-Consumer STD Testing Servicesstdcheck.com

STDcheck.com is a Houston-based direct-to-consumer online STD testing service that lets customers order FDA-approved tests online, visit 4,500+ CLIA-certified labs nationwide, and receive confidential results in 1-2 days. A subsidiary of Analyte Health, it has served over 2 million customers since 2010.

What STDcheck does

STDcheck.com is a Houston-based direct-to-consumer online STD testing service founded in 2010 by CEO Fiyyaz Pirani, operating as a subsidiary of Analyte Health under the legal entity FPK Services, LLC. The platform enables customers to order FDA-approved and cleared diagnostic tests online or by phone, visit any of 4,500+ CLIA-certified laboratory testing centers nationwide for sample collection, and receive confidential results within 1-2 days via a secure online account. Its catalog spans individual tests priced from $24 (Chlamydia, Gonorrhea, Hepatitis A/B/C, Herpes I & II, HIV antibody, Syphilis, Trichomoniasis, Mycoplasma Genitalium) up to a 10-Test Panel at $349 that includes the only FDA-approved HIV RNA Early Detection Test on the market, plus an extended 13-Test Panel with wellness screenings. The company refuses insurance billing to preserve privacy, supports payment via HSA/FSA and modern wallets, and offers free physician consultation with treatment prescription for positive results.

The business model is primarily transactional one-time test sales to consumers, supplemented by a 40% commission affiliate program through CJ Affiliate by Conversant, a B2B white-label partner program, and nonprofit/educational institute outreach programs that delivered 130,000+ tests in 2021. Customer segments include sexually active adults (primary), minors aged 16-17 served without parental consent, the LGBT community, and college students reached through programs such as the HIV-Positive Scholarship. The company has served over 2 million customers since founding, maintains a 9.8/10 rating across 5,236 reviews, and is BBB accredited, HIPAA-compliant, and FDA/CLIA-aligned, with no external funding rounds disclosed in the available sources.

STDcheck firmographics

Firmographics
Name
STDcheck
Legal name
FPK Services, LLC
Website
https://stdcheck.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
STDcheck.com is a Houston-based direct-to-consumer online STD testing service that lets customers order FDA-approved tests online, visit 4,500+ CLIA-certified labs nationwide, and receive confidential results in 1-2 days. A subsidiary of Analyte Health, it has served over 2 million customers since 2010.
Ownership category
akta.pro rank

STDcheck industry classification

Industry
Product category
Direct-to-Consumer STD Testing Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs

Keywords

  • Online STD testing
  • Sexual health screening
  • CLIA-certified lab diagnostics
  • Confidential lab testing
  • Direct-to-consumer diagnostics

Where STDcheck is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

STDcheck business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Marketing or Sales, Operations, Personnel, Technology or R&D, Others

Revenue model

  1. Direct Test Sales: One-time purchase of individual STD tests or panel packages. Customers pay upfront for testing services rendered at partner laboratory locations. Prices range from $24 for individual tests to $349 for comprehensive 10-Test Panel with HIV RNA Early Detection. Additional revenue from medical consultations for positive results.
  2. Affiliate Program: 40% commission on all referred customer purchases through CJ Affiliate by Conversant network. Affiliates receive recurring commissions from customer referrals who purchase within 45-day window.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual Tests - Starting at $24
Unit PricingPay-as-you-go10-Test Panel - $349 with HIV RNA
Unit PricingPay-as-you-go13-Test Panel - Expanded Coverage
Transaction based/ take ratePay-as-you-goAffiliate Commission - 40% Revenue Share

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

STDcheck product offering

Product offering

Core offering

STDcheck sells FDA-approved/cleared STD tests directly to consumers through its website and phone ordering. Customers order tests online, visit one of 4,500+ CLIA-certified testing centers for sample collection, and receive confidential results via a secure online portal within 1-2 days. The offering includes individual tests for specific infections and comprehensive 10-Test and 13-Test Panels, with free physician consultation and treatment prescriptions for positive results.

Product overview

STDcheck is an online STD testing platform offering FDA-approved/cleared diagnostic tests through a network of over 4,500 CLIA-certified testing centers nationwide. The core product is the online test ordering and results delivery service, available as comprehensive test panels (10-Test Panel, 13-Test Panel with wellness tests) or individual tests for specific infections including Chlamydia, Gonorrhea, Hepatitis A/B/C, Herpes I & II, HIV (antibody and RNA early detection), Syphilis, Trichomoniasis, and Mycoplasma Genitalium. The platform includes supplementary services such as physician consultation for positive results, an STD Test Recommender tool, and a B2B partner program for white-label services. Results are delivered within 1-2 days via secure online account. The company was founded in 2010 and has served over 2 million customers.

Differentiator

Problem solved

Functional benefit

Products and services

  • 10-Test Panel Comprehensive 10-disease STD screening panel including HIV-1, HIV-2, gonorrhea, chlamydia, syphilis, herpes 1 & 2, and hepatitis A, B, and C, priced at $349 with HIV RNA Early Detection included. Aimed at sexually active adults seeking a single comprehensive evaluation.
  • 13-Test Panel Most comprehensive screening panel covering 10 STDs plus Trichomoniasis, Mycoplasma Genitalium, and wellness tests, designed for broader coverage including HIV 1 & 2 (4th Gen), syphilis, gonorrhea, chlamydia, hepatitis A, B, C, trichomoniasis, mycoplasma genitalium, and herpes 1 & 2.
  • Chlamydia & Gonorrhea Panel Joint panel test for Chlamydia and Gonorrhea infections using FDA-approved/cleared methodology.
  • Herpes I & II Test Combined testing for oral herpes (HSV-1) and genital herpes (HSV-2) infections.
  • HIV 1 & 2 Antibody (4th Gen) Test FDA-cleared 4th generation HIV-1 and HIV-2 antibody test for standard-window HIV screening.
  • HIV RNA Early Detection Test Only FDA-approved HIV RNA Early Detection Test on the market. Detects HIV genetic material 9-11 days after exposure, earlier than antibody-based tests that require 30+ days.
  • Chlamydia Test Individual FDA-approved/cleared test for Chlamydia infection, available starting at $24.
  • Gonorrhea Test Individual FDA-approved/cleared test for Gonorrhea infection.
  • Hepatitis A Test Individual FDA-approved/cleared test for Hepatitis A infection.
  • Hepatitis B Test Individual FDA-approved/cleared test for Hepatitis B infection.
  • Hepatitis C Test Individual FDA-approved/cleared test for Hepatitis C infection.
  • Oral Herpes Test Individual FDA-approved/cleared test for oral herpes (HSV-1) infection.
  • Genital Herpes Test Individual FDA-approved/cleared test for genital herpes (HSV-2) infection.
  • Syphilis Test Individual FDA-approved/cleared test for Syphilis infection.
  • Trichomoniasis Test Individual FDA-approved/cleared test for Trichomoniasis infection.
  • Mycoplasma Genitalium Test Individual FDA-approved/cleared test for Mycoplasma Genitalium infection.
  • Doctor Consultation Free physician consultation service for patients who test positive, with licensed doctors reviewing results and able to prescribe treatment for the patient and partner.

Quantifiable outcome

  • Results delivered in 1-2 days vs 1-2 weeks at free clinics
  • +3 more outcomes

Companies that use STDcheck

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

STDcheck technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

STDcheck partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • Nonprofits and Educational InstitutesminorStrategic or Co-development Partner · 1 January 2022Partnerships with various nonprofits and educational institutes for STD testing programs. Testing over 130,000 people for genital herpes in 2021 through these partnerships.
  • LabCorpcoreTechnology or IntegrationLaboratory testing partner for STD testing services. CLIA-certified lab processing patient samples collected at testing centers.
  • Quest DiagnosticscoreTechnology or IntegrationLaboratory testing partner for STD testing services. CLIA-certified lab processing patient samples collected at testing centers.
  • CJ Affiliate by Conversant (Commission Junction)coreChannel Partner/ Reseller/ DistributorAffiliate marketing network managing partner relationships and commission tracking. STDcheck offers 40% commission on referred sales with 45-day cookie tracking through this network.
  • Analyte HealthcoreOthersParent company of STDcheck.com. STDcheck is a subsidiary of Analyte Health, which also operates Healthlabs.com, PaternityLabs.com, and UTITreatment.com sister sites.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

STDcheck competitors and assessment

Company assessment

Broad incumbents

  • Ro: Direct-to-consumer healthcare company offering telehealth, pharmacy, and at-home lab testing across multiple categories. Comparable patient-facing confidential health platform with significant capital backing, competing for the same DTC health consumer.
  • Quest Diagnostics: One of the two largest clinical laboratory companies in the US and an existing STDcheck lab partner. QuestDirect consumer offering directly competes with STDcheck while also powering its backend, creating both partnership and competitive tension.
  • Labcorp: One of the two largest clinical laboratory companies in the US and an existing STDcheck lab partner. Labcorp OnDemand consumer offering competes with STDcheck while also serving as its core processing infrastructure.
  • Hims & Hers Health: Large direct-to-consumer telehealth platform offering sexual health, hair loss, skincare, and primary care services. Comparable direct-to-consumer confidential care model for sensitive health categories, with significantly broader scope and brand recognition.

Direct peers

  • Nurx: Telehealth platform specializing in sexual and reproductive health including STD testing, PrEP, and birth control. Comparable confidential, direct-to-consumer care model for sexual health needs, though with stronger emphasis on telehealth consultations.
  • LetsGetChecked: Direct-to-consumer at-home diagnostic testing platform offering sexual health tests among many other categories. Competes with STDcheck on confidential testing with home sample collection and telehealth follow-up.
  • Health Testing Centers: Direct-to-consumer online lab testing service offering confidential STD and other health tests through partner labs. Closely mirrors STDcheck's online ordering, lab center visit, and fast result delivery model.
  • myLAB Box: At-home STD testing company offering FDA-cleared test kits shipped directly to consumers. Most direct competitor to STDcheck specifically focused on sexual health testing, with comparable pricing and confidentiality positioning.
  • Everlywell: Direct-to-consumer lab testing platform offering at-home test collection kits across multiple categories including sexual health. Closely comparable to STDcheck in offering FDA-cleared tests marketed directly to consumers with online ordering and physician-reviewed results.
  • Priority STD: Direct-to-consumer STD testing service using partner lab network, closely mirroring STDcheck's model of confidential online ordering with lab center visits for sample collection and fast result delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

STDcheck social profiles

Digital presence

STDcheck compliance and trust

Trust signal

Compliance4 records

STDcheck financial estimates

Financial estimate

Revenue estimate

Valuation estimate

STDcheck leadership team

Management profile

Number of profiles

Profiles3 records

STDcheck funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

STDcheck M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STDcheck

What does STDcheck do?

STDcheck sells FDA-approved/cleared STD tests directly to consumers through its website and phone ordering. Customers order tests online, visit one of 4,500+ CLIA-certified testing centers for sample collection, and receive confidential results via a secure online portal within 1-2 days. The offering includes individual tests for specific infections and comprehensive 10-Test and 13-Test Panels, with free physician consultation and treatment prescriptions for positive results.

Is STDcheck a public or private company?

STDcheck is a private company. It is classified as corporate owned and is currently operating.

When was STDcheck founded?

STDcheck was founded in 2010. It employs 11 to 50 people.

Where is STDcheck based?

STDcheck is headquartered in Houston, United States, in the North America region.

How does STDcheck make money?

Two revenue lines are on record. Direct Test Sales are the primary driver. The others are affiliate Program.

Who are STDcheck's main competitors?

Broad incumbents on record are Ro, Quest Diagnostics, Labcorp and Hims & Hers Health. Direct peers are Nurx, LetsGetChecked, Health Testing Centers, myLAB Box, Everlywell and Priority STD.

Does STDcheck have an API?

No public API is recorded for STDcheck.

What industry is STDcheck in?

STDcheck's product category is Direct-to-Consumer STD Testing Services. Its primary akta.pro industry code is HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits), with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HealthlineThe Best At-Home STD Kits for 2024Healthline compares at-home STD testing services, recommending Everlywell as the best overall. It details lab-based options like STDCheck and PrioritySTD, noting results in 1–3 days and costs from $24 to $198. The article also covers FDA authorization and CDC screening guidelines.YahooBest at-home syphilis tests of 2024, according to health expertsCDC data shows syphilis cases rose nearly 80% from 2018 to 2022, prompting expert recommendations for at-home testing. Four tests are compared: Everlywell, Nurx, STDCheck, and HealthLabs, with costs from $44.50 to $69 and results in 1-7 days. The article advises checking lab accreditation and follow-up care.PR NewswireSTDcheck.com Data Reveals Genital Herpes Rate Rose Average Of 56% In Super Bowl-Hosted Cities Last 3 YearsSTDcheck.com released research data showing that genital herpes rates rose an average of 56% year-over-year in the three most recent Super Bowl host cities over the past three years, with Miami (2020) seeing a 101.54% increase, Tampa (2021) a 50.39% increase, and Los Angeles (2022) a 16.82% increase.PR NewswireSTDcheck.com Is Now Accepting Cryptocurrency PaymentsSTDcheck.com, a leader in online STD testing, announced on February 9, 2018, that it will now accept payments in over 50 popular cryptocurrencies, including Bitcoin, Ethereum, and Litecoin. This move highlights the company's commitment to innovation and patient confidentiality, making it one of the largest corporations to adopt cryptocurrency payments. The decision reflects the growing popularity of cryptocurrencies and their potential applications in various industries.PR NewswireThe Top 100 Sex, Love & Lust Blogs Awarded By STDcheck.comSTDcheck.com, a Houston-based online STD testing provider, has released its list of the Top 100 Sex, Love & Lust blogs and websites, chosen and ranked based on writing quality, sex-positivity, and entertainment value. Each featured blogger will receive $500 in STDcheck.com gift cards to distribute to their readers. The company stated the list is part of its ongoing efforts to emphasize healthy relationships and sexual practices, with the CEO highlighting the importance of bloggers who address taboo topics online.PR NewswireNew scholarships for HIV-positive college students offered by STDcheck.comSTDcheck.com, a Houston-based provider of STD testing, has established a scholarship program exclusively for HIV-positive college students enrolled or accepted at U.S. colleges and universities. The scholarships range from $250 to $5,000, awarded monthly to applicants who submit transcripts, a 400-word essay, and undergo verification HIV testing. The initiative, announced in February 2016, represents the company's community outreach effort to support students dealing with the challenges of living with HIV.